Answer
Yes, human coagulation factor VIII replacement therapy may increase cardiovascular risk in patients with existing cardiovascular risk factors.
Sources for this answer
- Optivate powder and solvent for solution for injectionBio Products Laboratory Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked